{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:02Z","timestamp":1759333622757},"reference-count":14,"publisher":"Frontiers Media SA","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":715,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/tri.12185","type":"journal-article","created":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T04:29:10Z","timestamp":1377491350000},"page":"e110-e112","source":"Crossref","is-referenced-by-count":5,"title":["Fulminant hepatic failure necessitating transplantation following the initiation of infliximab therapy: a cautionary tale times two"],"prefix":"10.3389","volume":"26","author":[{"given":"Bradley W.","family":"Rowe","sequence":"first","affiliation":[{"name":"Department of Surgery; University of Alberta; Edmonton AB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Gala-Lopez","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Alberta; Edmonton AB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Alberta; Edmonton AB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safwat","family":"Girgis","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology; University of Alberta; Edmonton AB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A. M.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Alberta; Edmonton AB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2013,9,16]]},"reference":[{"key":"10.1111\/tri.12185-BIB0001|tri12185-cit-0001","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/rheumatology\/kep270","article-title":"Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients","volume":"48","author":"Aringer","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1111\/tri.12185-BIB0002|tri12185-cit-0002","first-page":"CD006893","article-title":"Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease","author":"Behm","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/tri.12185-BIB0003|tri12185-cit-0003","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10067-009-1179-y","article-title":"Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept","volume":"28","author":"Carlsen","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1111\/tri.12185-BIB0004|tri12185-cit-0004","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2165\/00044011-200626110-00008","article-title":"Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis","volume":"26","author":"Ierardi","year":"2006","journal-title":"Clin Drug Investig"},{"key":"10.1111\/tri.12185-BIB0005|tri12185-cit-0005","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/ibd.20230","article-title":"Occurrence of hepatoxicicty and elevated liver enzymes in a Crohn's disease patient treated with infliximab","volume":"13","author":"Moum","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/tri.12185-BIB0006|tri12185-cit-0006","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/ard.2009.112136","article-title":"Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis","volume":"69","author":"Sokolove","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/tri.12185-BIB0007|tri12185-cit-0007","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","article-title":"Serious liver disease induced by infliximab","volume":"26","author":"Tobon","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1111\/tri.12185-BIB0008|tri12185-cit-0008","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4065\/76.1.84","article-title":"Infliximab-associated reversible cholestatic liver disease","volume":"76","author":"Menghini","year":"2001","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1111\/tri.12185-BIB0009|tri12185-cit-0009","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/tri.12185-BIB0010|tri12185-cit-0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3109\/9781420021141-31","volume-title":"Drug-Induced Liver Disease","author":"Davern","year":"2007"},{"key":"10.1111\/tri.12185-BIB0011|tri12185-cit-0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11739-009-0342-4","article-title":"Infliximab-related hepatitis: discussion of a case and review of the literature","volume":"5","author":"Mancini","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1111\/tri.12185-BIB0012|tri12185-cit-0012","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1002\/ibd.21880","article-title":"Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate","volume":"17","author":"Subramaniam","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/tri.12185-BIB0013|tri12185-cit-0013","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.crohns.2012.01.017","article-title":"Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease","volume":"6","author":"Casteren-Messidoro","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1111\/tri.12185-BIB0014|tri12185-cit-0014","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrrheum.2010.214","article-title":"Hepatotoxicity related to antirheumatic drugs","volume":"7","author":"Aithal","year":"2011","journal-title":"Nat Rev Rheumatol"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12185","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12185\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:40:36Z","timestamp":1641062436000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,16]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12185","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,16]]}}}